MAPK3 and acute lymphoblastic leukemia: These data indicate that ERK1/2 signaling pathway contributes to attenuate dexamethasone-induced apoptosis in ALL cells by limiting Δψm collapse, ROS production, and cytochrome c release from mitochondria followed by caspase-3 activity.